The company announced on May 8 that it achieved a standalone revenue of 385.7 billion won and an operating profit of 21.2 billion won for the first quarter. This marks a 14.2% increase in revenue and a remarkable 464.3% rise in operating profit compared to the previous quarter.
SK Chemicals attributed its growth to increased sales in its core businesses, including copolyester and pharmaceuticals, amid ongoing economic uncertainty.
Despite a downturn in the global petrochemical market, the company is focusing on high-value specialty products centered around 'green chemistry' and expanding its recycling initiatives to defend its performance. However, when including its subsidiary SK Bioscience, the consolidated results showed revenue of 655.9 billion won and an operating loss of 18.9 billion won.
A representative from SK Chemicals stated, "Even in the first quarter, which faced significant external volatility, we were able to maintain a stable operation across sourcing, production, and sales, which helped sustain our revenue growth. We will continue to enhance our competitiveness by reviewing our product portfolio, cost structure, and operational processes to respond more flexibly to market changes and uncertainties such as fluctuations in oil prices and supply chain disruptions."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.